Clinical Trials in Phoenix

Showing 2801-2820 of 14,291 trials

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

NCT07187479

The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).

Chronic Kidney Disease (Stages 4 and 5)Kidney DiseaseType 2 Diabetes

Well Cell Global120 participantsStarted Oct 2025

Phoenix, Arizona, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

NCT06028438

The purpose of this study is to evaluate the efficacy of combination therapy with nipocalimab and certolizumab compared to certolizumab monotherapy.

Arthritis, Rheumatoid

Janssen Research & Development, LLC103 participantsStarted Aug 2023

Phoenix, Arizona, United States • Huntington Beach, California, United States • Upland, California, United States +29 more locations

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

Find Trials by Condition in Phoenix

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

SUBLOCADE Long-term Outcomes

Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors

Epigenetic Reprogramming in Relapse/Refractory AML

Neurophysiologic Biomarkers in Rett Syndrome

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

IN.PACT™ AV Access Post-Approval Study (PAS002)

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

PERIGON Pivotal Trial

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)